Clearance of Inflammatory Cytokines During Renal Replacement Therapy Using the EMIC®2 Filter
NCT03231748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2019-10-23
Summary
This study will be conducted in patients with sepsis and acute kidney injury needing renal replacement therapy.
The aim is to investigate whether continuous renal replacement therapy with the EMIC®2 filter leads to removal of pro-inflammatory middle molecular weight cytokines from the blood.
Conditions
- Acute Renal Failure
Sponsors & Collaborators
-
Guy's and St Thomas' NHS Foundation Trust
lead OTHER
Principal Investigators
-
Marlies Ostermann, PhD · Guy's & St Thomas Hospital London
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-01
- Primary Completion
- 2018-07-01
- Completion
- 2018-07-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
NCT05758077 ·Status: RECRUITING ·Phase: NA
-
PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy
NCT02341885 ·Status: COMPLETED
-
The Membrane Adsorbing OXiris Filter in Septic Patients With AKI
NCT03914586 ·Status: UNKNOWN
-
Citrate-based Regional Anticoagulation Versus Heparin for Continuous Renal Replacement Therapy
NCT01269112 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Citrate on the Coagulation System in Patients Receiving CRRT
NCT02486614 ·Status: COMPLETED
-
Hemodynamic Effects of Blood Flow Variation in Continuous Renal Replacement Therapy
NCT03078504 ·Status: TERMINATED ·Phase: NA
-
Prescription-based Fluid Management Versus Usual Care in Critically Ill Patients on KRT Trial in UK
NCT06471777 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Detecting Markers of Kidney Function With Intravenous Microdialysis
NCT03159806 ·Status: WITHDRAWN
-
Artificial Kidney Initiation in Kidney Injury
NCT01932190 ·Status: COMPLETED ·Phase: NA
-
Identification of Patients at Risk of CKD After AKI
NCT05740709 ·Status: RECRUITING
-
Immune Function in Acute Kidney Injury
NCT02470507 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury
NCT04445259 ·Status: UNKNOWN
-
Precision Medicine Approach to Unravel the Risk Factors for Renal, Cardiovascular, Ophthalmologic, Neurologic and Hepatic Complications of Metabolic Disorders
NCT05307172 ·Status: WITHDRAWN
-
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
NCT01072682 ·Status: COMPLETED ·Phase: NA
-
Cytokine Adsorption in Sepsis and Acute Kidney Injury
NCT02588794 ·Status: UNKNOWN ·Phase: NA
-
Ultrasound-Guided Microbubble Removal and Filter Lifespan During CRRT: A Pilot Crossover Study
NCT07005531 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hemofilter Life Span, ECLS And/or CRRT
NCT04193865 ·Status: COMPLETED
-
HEmoFiltration With Citric Acid Anticoagulation
NCT03836742 ·Status: COMPLETED
-
A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure
NCT00565994 ·Status: COMPLETED
-
Essential Nutrients in Critically Ill Patients With Severe AKI Treated With and Without CRRT
NCT02470520 ·Status: COMPLETED
-
Metabolic Reprogramming in Renal Tubular Cells in Acute Kidney Injury Following Severe Trauma
NCT06167512 ·Status: RECRUITING
-
Hemo Filtration Reinfusion (HFR) Clearance Efficiency Towards P-bound Toxins and Effects on Inflammatory and Endothelial Damage Markers
NCT02240004 ·Status: COMPLETED
-
Pharmacokinetics of Ertapenem in Continuous Venovenous Hemodialysis
NCT00877370 ·Status: COMPLETED ·Phase: PHASE4
-
Lithium Clearance in Patients With High Risk of Acute Kidney Injury
NCT05648435 ·Status: COMPLETED
-
Acute Renal Failure Trial Network (ATN) Study
NCT00076219 ·Status: COMPLETED ·Phase: PHASE3